143 related articles for article (PubMed ID: 20167484)
21. Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
Ciabatti R; Tarzia G; Battaglia F; Barone D; Baldoli E
Farmaco Sci; 1988 Dec; 43(12):989-1003. PubMed ID: 2854788
[TBL] [Abstract][Full Text] [Related]
22. Eco-friendly synthesis and in vitro antibacterial activities of some novel chalcones.
Khan SA; Asiri AM; Alamry KA; El-Daly SA; Zayed MA
Bioorg Khim; 2013; 39(3):353-7. PubMed ID: 24397034
[TBL] [Abstract][Full Text] [Related]
23. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
[TBL] [Abstract][Full Text] [Related]
24. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
25. Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
Seo WD; Kim JH; Kang JE; Ryu HW; Curtis-Long MJ; Lee HS; Yang MS; Park KH
Bioorg Med Chem Lett; 2005 Dec; 15(24):5514-6. PubMed ID: 16202584
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of some chalcones and pyrazolines carrying morpholinophenyl moiety as potential anti-inflammatory agents.
Khalil OM
Arch Pharm (Weinheim); 2011 Apr; 344(4):242-7. PubMed ID: 21469173
[TBL] [Abstract][Full Text] [Related]
28. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE).
Melzig MF; Pieper S; Siems WE; Heder G; Bóttger A; Liberra K; Lindequist U
Pharmazie; 1996 Jul; 51(7):501-3. PubMed ID: 8774843
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide.
Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Pillai KK; Singh S; Bagchi V
Bioorg Med Chem Lett; 2009 Jan; 19(1):255-8. PubMed ID: 19010670
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans.
Park PJ; Je JY; Kim SK
J Agric Food Chem; 2003 Aug; 51(17):4930-4. PubMed ID: 12903948
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with an omega-aminoalkyl group.
Saito S; Matsui S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 Mar; 40(3):257-60. PubMed ID: 2346534
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of novel triazoles and mannich bases functionalized 1,4-dihydropyridine as angiotensin converting enzyme (ACE) inhibitors.
Kumbhare RM; Kosurkar UB; Bagul PK; Kanwal A; Appalanaidu K; Dadmal TL; Banerjee SK
Bioorg Med Chem; 2014 Nov; 22(21):5824-30. PubMed ID: 25300819
[TBL] [Abstract][Full Text] [Related]
33. Flavonoids from the buds of Rosa damascena inhibit the activity of 3-hydroxy-3-methylglutaryl-coenzyme a reductase and angiotensin I-converting enzyme.
Kwon EK; Lee DY; Lee H; Kim DO; Baek NI; Kim YE; Kim HY
J Agric Food Chem; 2010 Jan; 58(2):882-6. PubMed ID: 20038104
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis.
Lee JK; Hong S; Jeon JK; Kim SK; Byun HG
Bioresour Technol; 2009 Nov; 100(21):5255-9. PubMed ID: 19540110
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of chalcone analogues based pyrimidines as angiotensin converting enzyme inhibitors.
Bukhari SN; Butt AM; Amjad MW; Ahmad W; Shah VH; Trivedi AR
Pak J Biol Sci; 2013 Nov; 16(21):1368-72. PubMed ID: 24511749
[TBL] [Abstract][Full Text] [Related]
36. Complete assignments of 1H and 13C NMR data for 21 naphthalenyl-phenyl-pyrazoline derivatives.
Hwang D; Yoon H; Ahn S; Kim DW; Bae DH; Koh D; Lim Y
Magn Reson Chem; 2013 Sep; 51(9):593-9. PubMed ID: 23813616
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, spectroscopic and computational characterization of the tautomerism of pyrazoline derivatives from chalcones.
Miguel FB; Dantas JA; Amorim S; Andrade GF; Costa LA; Couri MR
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():318-26. PubMed ID: 26232575
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of new pyrazolone and pyrazole-based adamantyl chalcones and antimicrobial activity.
Al-Saheb R; Makharza S; Al-Battah F; Abu-El-Halawa R; Kaimari T; Abu Abed OS
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32914839
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis of N-(4-carbomethoxy-4-phthalimidobutanoyl)-N-substituted glycines, proline and pyroglutamic acid].
Lin WQ; Cai CY; Gong KS; Wu Y; Long Z; Luo XX; Yang L; Li JF; Yao XJ
Yao Xue Xue Bao; 1994; 29(5):346-54. PubMed ID: 7976352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
